Back to Rankings

MLAB

Mesa LaboratoriesD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
Current thesis
The bull case is that FY26 closed with modest revenue growth, a sharp AOI margin step-up, and lower leverage, while management signaled that SDC strength and easing export controls could help FY27 core growth recover. If the H1 guidance update confirms the BPD problems are temporary rather than structural, the earnings power story improves meaningfully.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
BPD commercial execution and export-control-related shipping delays remain the clearest near-term operating risk; management explicitly flagged both in the release. [#8-K-2026-05-27]
Momentum
19
Value
64
Sentiment
45
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $101.00 · Bull $117.00 · Bear $78.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-29 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $112.00
Why
Momentum19 · Δ7d -0.7
Value64 · Δ7d -0.3
Sentiment45 · Δ7d -6.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
19
26% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-45.5
Value
64
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.0
Sentiment
45
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.0
Δ21d
+2.5
Why this grade

Composite grade D. Momentum 18.9 / Value 64.4 / Sentiment 45.2

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$534.1M
Beta
0.88
Shares Out
5.52M
P/E (TTM) · Derived
79.4
P/S (TTM)
1.96
P/FCF (TTM)
17.38
Rev YoY
+2.6%
EPS YoY
-43.0%
Gross Margin
+56.6%
Op Margin
+6.1%
Net Debt
$141.9M
Current Ratio
1.72
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology